Abstract
Background Greater maternal adiposity before or during pregnancy is associated with greater offspring adiposity throughout childhood, but the extent to which this is due to causal intrauterine or periconceptional mechanisms remains unclear. Here we use Mendelian Randomization (MR) with polygenic risk scores (PRS) to investigate whether associations between maternal pre-/early pregnancy body mass index (BMI) and offspring adiposity from birth to adolescence are causal.
Methods We undertook confounder adjusted multivariable (MV) regression and MR using mother-offspring pairs from two UK cohorts: Avon Longitudinal Study of Parents and Children (ALSPAC) and Born in Bradford (BiB). In ALSPAC and BiB the outcomes were birthweight (BW; N = 9339) and BMI at age 1 and 4 years (N = 8659 to 7575). In ALSPAC only we investigated BMI at 10 and 15 years (N = 4476 to 4112) and dual-energy X-ray absorptiometry (DXA) determined fat mass index (FMI) from age 10–18 years (N = 2659 to 3855). We compared MR results from several PRS, calculated from maternal non-transmitted alleles at between 29 and 80,939 single nucleotide polymorphisms (SNPs).
Results MV and MR consistently showed a positive association between maternal BMI and BW, supporting a moderate causal effect. For adiposity at most older ages, although MV estimates indicated a strong positive association, MR estimates did not support a causal effect. For the PRS with few SNPs, MR estimates were statistically consistent with the null, but had wide confidence intervals so were often also statistically consistent with the MV estimates. In contrast, the largest PRS yielded MR estimates with narrower confidence intervals, providing strong evidence that the true causal effect on adolescent adiposity is smaller than the MV estimates (Pdifference = 0.001 for 15 year BMI). This suggests that the MV estimates are affected by residual confounding, therefore do not provide an accurate indication of the causal effect size.
Conclusions Our results suggest that higher maternal pre-/early-pregnancy BMI is not a key driver of higher adiposity in the next generation. Thus, they support interventions that target the whole population for reducing overweight and obesity, rather than a specific focus on women of reproductive age.
Competing Interest Statement
DAL has received support from numerous national and international government and charity funders and from Medtronic LTD and Roche Diagnostics for research unconnected with that presented in this study. DAL is an associate editor for BMC Medicine. GCP is an employee of 23andMe Inc and may hold stock or stock options. All other authors report no conflict of interest.
Funding Statement
The UK Medical Research Council and Wellcome (102215/2/13/2) and the University of Bristol provide core support for ALSPAC. Genotyping of the ALSPAC maternal samples was funded by the Wellcome Trust (WT088806) and the offspring samples were genotyped by Sample Logistics and Genotyping Facilities at the Wellcome Trust Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). BiB receives core infrastructure funding from the Wellcome Trust (WT101597MA), a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) (MR/N024397/1), the British Heart Foundation (CS/16/4/32482) and the National Institute for Health Research (NIHR) under its Applied Research Collaboration Yorkshire and Humber (NIHR200166). Further support for genome-wide data is from the UK Medical Research Council (G0600705) and the National Institute of Health Research (NF-SI-0611-10196). The work presented here was supported by the US National Institute of Health (R01 DK10324), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement (669545) and the British Heart Foundation (AA/18/7/34219). TAB is supported by the Medical Research Council (MRC) (UK) (MR/K501281/1), TAB and DME are supported by the NHMRC (Australia) (GNT1183074 and GNT1157714), DAL, TAB, MCB and RCR work in/are affiliated with a unit that is supported by the UK Medical Research Council (MC_UU_00011/1 & MC_UU_00011/6) and DAL is a British Heart Foundation Chair (CH/F/20/90003) and NIHR Senior Investigator (NF-0616-10102). DAL, MCB and TAB are supported by the British Heart Foundation Accelerator Award at the University of Bristol (AA/18/7/34219). MCB's contribution to this work was supported by a UK MRC Skills Development Fellowship (MR/P014054/1). VK is funded by the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant (721567). MRJ is funded by EU-H2020 LifeCycle Action (733206) which also supports DAL's research, EU-H2020 EDCMET (825762), EU-H2020 EUCAN Connect (824989), EU H2020-MSCA-ITN-2016 CAPICE Marie Sklodowska-Curie grant (721567) and the MRC (UK) (MRC/BBSRC MR/S03658X/1 [JPI HDHL]). RCR is a de Pass Vice Chancellor's Research Fellow at the University of Bristol. AL and MRJ are supported by the MRC (UK) (MR/M013138/1) and the European Union Horizon 2020 programme (633595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees, and Bradford National Health Service Ethics Committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The ALSPAC study website (http://www.bristol.ac.uk/alspac/researchers/our-data/) contains details of all the data that are available through a fully searchable data dictionary and variable search tool. Scientists are encouraged and able to use BiB data. Data requests are made to the BiB executive using the form available from the study website http://www.borninbradford.nhs.uk (please click on ‘Science and Research’ to access the form). Guidance for researchers and collaborators, the study protocol and the data collection schedule are all available via the website. All requests are carefully considered and accepted where possible. UK Biobank data are available from the UK Biobank (http://biobank.ndph.ox.ac.uk/showcase/).
Abbreviations
- ALSPAC
- Avon Longitudinal Study of Parents and Children
- BiB
- Born in Bradford
- BMI
- body mass index
- DXA
- dual-energy X-ray absorptiometry
- FMI
- fat mass index
- GWAS
- genome wide association study
- GWS
- genome wide significant (P < 5e-8)
- IV
- instrumental variable
- LMM
- linear mixed model
- MR
- Mendelian randomization
- MV
- multivariable
- NCMP
- UK Government National Child Measurement Programme
- PC
- principal component
- PRS
- polygenic risk score(s)
- QC
- quality control
- SD
- standard deviation
- TSLS
- two-stage least squares
- UKB
- UK Biobank
- SNP
- single nucleotide polymorphism
